A study to see that - How does giving a medicine called Lidocaine during operation, affect a patients recovery after the operation is over.

A Randomised Controlled Study to Evaluate the effects of Systemic Lidocaine on Postoperative Quality of Recovery in patients undergoing Gynaecological Laparoscopic Surgery.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011760

Enrollment

Registered

2018-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing Gynaecological laparoscopic surgery

Interventions

Intervention1: Lidocaine: Intravenous lidocaine 1.5 mg/kg bolus just prior to induction and a lidocaine infusion was commenced at 2 mg/kg/hr,which was stopped after conclusion of surgery. Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: Undergoing Gynaecological Laparoscopic Surgery

Exclusion criteria

Exclusion criteria: History of allergy to local anaesthetic Chronic use of opioid analgesics Corticosteroid use Drug or alcohol abuse Pregnancy

Design outcomes

Primary

Measure	Time frame
Global QoR-40 scoreTimepoint: At 24 hours	—

Secondary

Measure	Time frame
1. Pain score (NRS) 2. Incidence of Nausea/vomiting 3. PADSS score in PACU 4. Analgesic consumptionTimepoint: 1. On arrival in PACU and at 24 hours 2. In PACU 3. PADSS score in PACU 4. Within 24 hours period.	—

Countries

India

Contacts

Public ContactDr Shikha Awal

Maulana Azad Medical College and Lok Nayak Hospital, New Delhi

drakgk@yahoo.co.in9968604219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026